Conference News

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

Featured

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer patients.

By Caitlin E. Cox

November 18, 2024

Latest Conference News

See All

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

By Yael L. Maxwell

November 20, 2024
Talking Sex: CVD Patients Want to Hear More From Clinicians

By Caitlin E. Cox

November 20, 2024
AI Poised to Change the Landscape of Echocardiography

By Yael L. Maxwell

November 19, 2024
Extreme Heat Seems to Spark More Atrial Arrhythmias in IED Patients

By Todd Neale

November 19, 2024
Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

By Michael O'Riordan

November 18, 2024
OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

By Todd Neale

November 18, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.